AJOVista LLC Buys Shares of 6,247 Kenvue Inc. (NYSE:KVUE)

AJOVista LLC purchased a new position in Kenvue Inc. (NYSE:KVUE) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 6,247 shares of the company’s stock, valued at approximately $134,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Beaumont Financial Advisors LLC boosted its position in Kenvue by 3.0% in the 4th quarter. Beaumont Financial Advisors LLC now owns 17,532 shares of the company’s stock valued at $377,000 after buying an additional 509 shares during the period. Pinnacle Bancorp Inc. raised its position in Kenvue by 51.3% during the 4th quarter. Pinnacle Bancorp Inc. now owns 1,552 shares of the company’s stock valued at $33,000 after purchasing an additional 526 shares in the last quarter. Dfpg Investments LLC lifted its holdings in shares of Kenvue by 2.3% in the 4th quarter. Dfpg Investments LLC now owns 26,659 shares of the company’s stock worth $567,000 after buying an additional 589 shares during the period. Mutual Advisors LLC grew its position in shares of Kenvue by 6.1% during the 4th quarter. Mutual Advisors LLC now owns 10,606 shares of the company’s stock worth $228,000 after buying an additional 612 shares in the last quarter. Finally, Baron Wealth Management LLC increased its stake in shares of Kenvue by 7.5% during the fourth quarter. Baron Wealth Management LLC now owns 12,915 shares of the company’s stock valued at $278,000 after buying an additional 899 shares during the period. 97.64% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently weighed in on KVUE shares. William Blair began coverage on shares of Kenvue in a research note on Wednesday, April 3rd. They issued a “market perform” rating for the company. Royal Bank of Canada dropped their price objective on shares of Kenvue from $25.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, February 9th. Sanford C. Bernstein initiated coverage on shares of Kenvue in a research note on Thursday, April 11th. They issued an “underperform” rating and a $18.00 price objective for the company. The Goldman Sachs Group began coverage on Kenvue in a research report on Friday, March 1st. They issued a “neutral” rating and a $20.00 price target for the company. Finally, JPMorgan Chase & Co. dropped their price objective on Kenvue from $25.00 to $24.00 and set an “overweight” rating on the stock in a research report on Friday, February 9th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $24.85.

Kenvue Price Performance

Kenvue stock traded up $0.08 during mid-day trading on Friday, reaching $19.20. 15,941,057 shares of the company traded hands, compared to its average volume of 15,351,688. The firm’s fifty day moving average is $19.82 and its two-hundred day moving average is $20.11. Kenvue Inc. has a fifty-two week low of $17.82 and a fifty-two week high of $27.80. The company has a current ratio of 1.12, a quick ratio of 0.78 and a debt-to-equity ratio of 0.69.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, February 8th. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.28 by $0.03. The company had revenue of $3.67 billion during the quarter, compared to analyst estimates of $3.78 billion. Kenvue had a return on equity of 15.62% and a net margin of 9.87%. The business’s revenue for the quarter was down 2.7% compared to the same quarter last year. Sell-side analysts anticipate that Kenvue Inc. will post 1.15 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 22nd. Investors of record on Wednesday, May 8th will be issued a $0.20 dividend. The ex-dividend date is Tuesday, May 7th. This represents a $0.80 annualized dividend and a yield of 4.17%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.